- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Lenvatinib – November 2017
Lenvatinib: Capsule 10 mg (as mesilate), Capsule 4 mg (as mesilate); Lenvima®
Last updated
16 March 2018